Depending on the stage of the disease, the most common treatments are surgical removal of the affected tissues, chemotherapy, or radiation. There is some concern that research into mesothelioma will be minimal, because it is projected to be a short-lived disease in terms of new cases after the next 30 years. However, new research is consistently providing physicians with alternate forms of therapy, and there are many intense studies into control and cure of the disease, so those diagnosed with mesothelioma do have many options and a lot of hope.
Photodynamic therapy is a new approach to treating mesothelioma cancer and is based on using light to kill the cancer cells. In photodynamic therapy, a drug is first administered intravenously that targets and renders the cancerous cells more sensitive in a number of days. The drug is easily eliminated by normal cells, ensuring that they will not be harmed when light therapy is given. After the cells have been given the proper time of exposure to the drug, a special frequency of light laser beams are directed towards the mesothelioma cancer with the intent to eradicate it from the body without having to use more invasive methods. Although there are occasional cases of eye sensitivity and nausea and/or vomiting, the main side effect of photodynamic therapy is skin sensitivity after the procedure is completed.
More information on photodynamic therapy can be found on new Web site, Mesothelioma Help) The Web site contains several informative articles, including a primer on emerging treatments for mesothelioma.
The Web site was a joint product of Meso Marketing and Meso Corp. Said editor Jimmy Atk, "We wanted to make a site that can actually help those coping with mesothelioma, rather than just another 'A-O #1 Spam' site. This is a hard thing to face, and it's sad to see ambulance-chasers dominating this field. We aim to change that with Mesothelioma Info."
Meso Marketing is a privately held company based in BH, California. For more information. Visit Meso Corp. Visit Mesothelioma Help at
David Williams, Editor